{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:55:09Z","timestamp":1789962909574,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.bbr.2015.03.025","type":"journal-article","created":{"date-parts":[[2015,4,4]],"date-time":"2015-04-04T02:31:01Z","timestamp":1428114661000},"page":"120-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The serotonin 5-HT1A receptor agonist tandospirone improves executive function in common marmosets"],"prefix":"10.1016","volume":"287","author":[{"given":"Satoko","family":"Baba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Nakako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2015.03.025_bib0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the right stuff","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbr.2015.03.025_bib0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2015.03.025_bib0140","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2015.03.025_bib0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbr.2008.05.016","article-title":"Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia","volume":"195","author":"Meltzer","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.03.025_bib0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-642-25761-2_4","article-title":"Serotonergic mechanisms as targets for existing and novel antipsychotics","volume":"212","author":"Meltzer","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.bbr.2015.03.025_bib0155","first-page":"357","article-title":"Facilitative effect of serotonin(1A) receptor agonists on cognition in patients with schizophrenia","volume":"20","author":"Sumiyoshi","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bbr.2015.03.025_bib0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1163\/1569391041501933","article-title":"Effects of tandospirone, a novel anxiolytic agent, on human 5-HT1A receptors expressed in Chinese hamster ovary cells (CHO cels)","volume":"18","author":"Yabuuchi","year":"2004","journal-title":"Biog Amines"},{"key":"10.1016\/j.bbr.2015.03.025_bib0165","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0006-3223(00)01025-8","article-title":"The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia","volume":"49","author":"Sumiyoshi","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2015.03.025_bib0170","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1176\/appi.ajp.158.10.1722","article-title":"Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment","volume":"158","author":"Sumiyoshi","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2015.03.025_bib0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-011-2561-4","article-title":"The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats","volume":"221","author":"Horiguchi","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2015.03.025_bib0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/schbul\/sbi020","article-title":"A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia","volume":"31","author":"Buchanan","year":"2005","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbr.2015.03.025_bib0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbr.2007.08.012","article-title":"Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats","volume":"186","author":"Enomoto","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.03.025_bib0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2007.06.058","article-title":"Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test","volume":"572","author":"Ishiyama","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2015.03.025_bib0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2013.02.019","article-title":"Effects of lurasidone on executive function in common marmosets","volume":"246","author":"Murai","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.03.025_bib0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2013.11.036","article-title":"Lack of dopamine D4 receptor affinity contributes to the procognitive effect of lurasidone","volume":"261","author":"Murai","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.03.025_bib0205","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1046\/j.0953-816x.2001.01546.x","article-title":"Dissociable contributions of the orbitofrontal and lateral prefrontal cortex of the marmoset to performance on a detour reaching task","volume":"13","author":"Wallis","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2015.03.025_bib0210","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0306-4522(97)00075-4","article-title":"Contrasting effects of excitotoxic lesions of the prefrontal cortex on the behavioural response to D-amphetamine and presynaptic and postsynaptic measures of striatal dopamine function in monkeys","volume":"80","author":"Wilkinson","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2015.03.025_bib0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2013.04.012","article-title":"Effects of a dopamine D1 agonist on ketamine-induced spatial working memory dysfunction in common marmosets","volume":"249","author":"Nakako","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.03.025_bib0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00213-007-0999-1","article-title":"Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques","volume":"196","author":"Rutten","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2015.03.025_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphs.2015.01.007","article-title":"Blonanserin extensively occupies rat dopamine D3 receoits at antipsychotic dose range","author":"Baba","year":"2015","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bbr.2015.03.025_bib0230","first-page":"845","article-title":"Dopamine-serotonin antagonist: Receptor biding profile of a novel antipsychotic blonanserin","volume":"11","author":"Murasaki","year":"2008","journal-title":"Jpn J Clin Psychopharmacol"},{"key":"10.1016\/j.bbr.2015.03.025_bib0235","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbr.2013.03.027","article-title":"Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT(1A) partial agonism","volume":"247","author":"Horiguchi","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.03.025_bib0240","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/jnc.12512","article-title":"Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin 5-HT2A and DA D2 antagonism and 5-HT1A partial agonism","volume":"128","author":"Huang","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2015.03.025_bib0245","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(01)00079-1","article-title":"Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex","volume":"40","author":"Yoshino","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2015.03.025_bib0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-004-1793-y","article-title":"Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction","volume":"174","author":"Goldman-Rakic","year":"2004","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815001904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815001904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T23:52:49Z","timestamp":1537746769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432815001904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":25,"alternative-id":["S0166432815001904"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2015.03.025","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The serotonin 5-HT1A receptor agonist tandospirone improves executive function in common marmosets","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2015.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}